The International Society for the History of the Neurosciences (ISHN) invites you to present your latest historical research at its annual meeting - Lisbon, July 6-11 2026 !
For more information, please visit our conference website: ishn2026.com

Deeply honored to share that I have been elected as a Distinguished Associate of the @aanmember.bsky.social (DAAN). The AAN has been a cornerstone of my #professionalgrowth : looking forward to contributing to its mission and to the pursuit of excellence & innovation in neurology.🧠

The newest @movedisorder.bsky.social Moving Along newsletter features an interview with Dr. Zuzana Košutzká and me about the #LEAP program — take a look!➡️ movementdisorders.org/Moving-Along...

The 2025 @movedisorder.bsky.social congress offered a valuable opportunity to present some of my research projects (end-of-life care, representation of women in Parkinson’s disease research, & gender publishing gaps within the field of movement disorders) and to contribute to the Charcot exhibition.

Proud to share that I’ve officially graduated from the @movedisorder.bsky.social LEAP Leadership Program. I
am deeply grateful to my mentors, the MDS/LEAP faculty and my 2024 LEAP peers.

💡Pleased to share the publication of our
@movedisorder.bsky.social review on a highly underexplored topic: #pregnancy in women with early-onset #Parkinson’s disease (EOPD).

📖 Read the full article here (Open Access) : movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...

💡Hot off the press: thrilled to share our latest article on #neuropalliative care in #Parkinson's disease, crafted to be a useful tool for clinicians, patients, and their families alike, is just out in @springernature.com ➡️
link.springer.com/article/10.1...

Interested in the #historyofneuroscience and/or the contribution of #women to the history of science? 🧠 🚺
Then don’t wait any longer to discover our latest article, just out in the Journal of the National Medical Association ➡️ authors.elsevier.com/c/1lTsU6M-e2...

💡Hot off the press: thrilled to share my latest open-access article on #apomorphine history & clinical relevance ➡️ prd-journal.com/article/S135...
I hope you'll enjoy reading it as much as I enjoyed writing it !

📌 Bientôt disponible ! 📌Pour inaugurer ce #PDawarenessmonth, ne manquez pas de précommander la cinquième édition de la monographie de référence Elsevier Masson sur la maladie de #Parkinson ➡️ elsevier-masson.fr/la-maladie-d...

Join us July 1-5 in Paris (FR🥖) for the 200th anniversary of the birth of Jean-Martin #Charcot, at historical @pitiesalpetriere.bsky.social, for the 2025 International Society for the History of the Neurosciences (ISHN)
annual meeting, organized by ISHN President Olivier Walusinski ➡️ charcot2025.fr

DV à 19h au MOBE pour une conférence dédiée à la santé cérébrale 🧠 (#BrainHealth) dans le cadre de la @semaineducerveau.bsky.social à Orléans !
CC @chuorleans.bsky.social

C'est le début de la @semaineducerveau.bsky.social à #Rennes ! Je vous donne RDV ce soir à 18h30 pour une conférence inaugurale consacrée à la santé 🧠 (#BrainHealth) et ses enjeux individuels & sociétaux. Entrée gratuite, sans inscription !

Such an honor to have contributed to this very important JAMA Neurology (@jama.com) special communication on the critical needs of #neuropalliative care research, among many dedicated colleagues. 🙏 A must read for all interested in #neuropal and #Neurology ! ➡️ ja.ma/4hlgKNL

The #apomorphine infusion is finally FDA-approved for #Parkinson's disease ➡️ ir.supernus.com/news-release...

Merci à la #SFGG et au Prof. Verny (APHP) pour leur invitation aux 44e Journées Annuelles de la Société Française de #Gériatrie et Gérontologie. L'occasion de présenter nos travaux sur l'approche #neuropalliative de la maladie de #Parkinson à la communauté gériatrique !